Study of plasma protein C and inflammatory pathways: Biomarkers for dimethylnitrosamine-induced liver fibrosis in rats

European Journal of Pharmacology

Volumn 575, Issue 1-3, 2007, Pages 158-167

  Saha, Joy K ^a   Xia, Jinqi ^a   Sandusky, George E ^a   Chen, Yun Fei ^a   Gerlitz, Bruce ^a   Grinnell, Brian ^a   Jakubowski, Joseph A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Biomarker; Chemokine; Dimethylnitrosamine; Inflammation; Liver enzyme; Liver fibrosis; Liver histopathology; Protein C; sICAM 1

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CHEMOKINE; COLONY STIMULATING FACTOR 1; DIMETHYLNITROSAMINE; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN; HYALURONIC ACID; INTRACELLULAR ADHESION MOLECULE 1; LIVER ENZYME; MACROPHAGE DERIVED CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PROTEIN; PROTEIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG TARGETING; HISTOPATHOLOGY; INFLAMMATION; LIVER FIBROSIS; LIVER FUNCTION; MALE; MONOCYTE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS INHIBITION; RAT; TREATMENT PLANNING;

ANIMALS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHEMOKINES; DIMETHYLNITROSAMINE; FIBRINOLYTIC AGENTS; GAMMA-GLUTAMYLTRANSFERASE; HAPTOGLOBINS; HUMANS; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LIVER CIRRHOSIS; MACROPHAGE COLONY-STIMULATING FACTOR; NEUTROPHILS; PROTEIN C; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN; TIME FACTORS;

EID: 35348839103     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.07.052     Document Type: Article

References (40)

1. Abdalla A., Sheesha A.G., Shokeir M., El-Agrody O., El-Rega l.M.E., Abdel-Khalik M., Freeman K., Boneberg A., and A-Kader H. Serum intracellular adhesion molecule-1 in children with chronic liver disease: relationship to disease activity. Dig. Dis. Sci. 47 (2002) 1206-1208
2. Al Ghumlas A.K., Abdel Gadir A.G.M., and Al Faleh F.Z. Haemostatic abnormalities in liver disease: could some haemostatic tests be useful as liver function tests?. Blood Coagul. Fibrinolysis, 16 (2005) 329-335
3. Ala-Kokko L., Pihalajaniemi T., Myers J.C., Kivirikko K.I., and Savolainen E.R. Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochem. J. 244 (1987) 75-79
4. Bataller R., and Brenner D.A. Liver fibrosis. J. Clin. Invest. 115 (2005) 209-218
5. Bell H., Odegaard O.R., Andersson T., and Raknerud N. Protein C in patients with alcoholic cirrhosis and other liver diseases. J. Hepatol. 14 (1992) 163-167
6. Berg D.T., Gerlitz B., Shang J., Smith T., Santa P., Richardson M.A., Kurz K.D., Grinnell B.W., Mace K., and Jones B.E. Engineering the proteolytic specificity of activated protein C improves its pharmacological properties. Proc. Natl. Acad. Sci. 100 (2003) 4423-4428
7. Capra F., Maria E.D., Lunardi C., Marchiori L., Mezzelani P., Beri R., and Gabrielli G.B. Serum level of soluble intercellular adhesion molecule-1 in patients with chronic liver disease related to hepatitis C virus: a prognostic marker for responses to interferon treatment. J. Inf. Dis. 181 (2000) 425-431
8. George J., and Chandrakasan G. Biochemical abnormalities during the progression of hepatic fibrosis induced by dimethylnitrosamine. Clin. Biochem. 33 (2000) 563-570
9. George J., Rao K.R., Stern R., and Chandrakasan G. Dimethylnitrosamine-induced liver injury in rats: The early deposition of collagen. Toxicology 156 (2001) 129-135
10. George J., Tsutsumi M., and Takase S. Expression of hyaluronic acid in N-dimethylnitrosamine induced hepatic fibrosis in rats. Int. J. Biochem. Cell. Biol. 36 (2004) 307-319
11. Grinnell B.W., and Joyce D. Recombinant human aPC: a system modulator of vascular function for treatment of severe sepsis. Crit. Care Med. 29 7 Suppl (2001) S53-S61
12. Heuer J.G., Sharma G.R., Gerlitz B., Zhang T., Bailey D., Ding C., Berg D.T., Perkins F.D., Stephens E.J., Holmes K.C., Grubbs R.L., Fynboe K.A., Chen Y., Grinnell B., and Jakubowski J.A. Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis. Crit. Care Med. 32 (2004) 1570-1578
13. Heydtmann M., Shields P., McCaughan G., and Adams D. Cytokines and chemokines in the immune response to hepatitis C infection. Curr. Opin. Infect. Dis. 14 (2001) 279-287
14. Jenkins S.A., Grandison A., Bazter J.N., Day D.W., Taylor I., and Shields R.A. Dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat. J. Hepatol. 1 (1985) 489-499
15. Jezequel A.M., Mancini R., Rinaldesi M.L., Macarri G., Venturini C., and Orlandi F.A. Morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J. Hepatol. 5 (1987) 174-181
16. Kloczko J., Mian M., Wojtukiewicz M.Z., Babiuch L., Bielawiec M., and Galar M. Plasma protein C as a marker of hepatocellular damage in alcoholic liver disease. Haemostasis 22 (1992) 340-344
17. Kornek M., Raskopf E., Guetgemann I., Ocker M., Gerceker S., Gonzalez-Carmona M.A., Rabe C., Saurbruch T., and Schmitz V. Combination of systemic thioacetate (TAA) injections and ethanol feeding accelerates hepatic fibrosis in C3H/He mice and is associated with intrehepatic up regulation of MMP-2, VEGF and ICAM-1. J. Hepatol. 45 (2006) 370-376
18. Matsukawa A., Kaplan M.H., Hogaboam C.M., Lukacs N.W., and Kunkel S.L. Pivotal role of signal transducer and activator of transcription Stat4 and Stat6 in the innate immune response during sepsis. J. Exp. Med. 193 (2001) 679-688
19. McHutchison J.G., Blatt L.M., de Medina M., Craig J.R., Conrad A., Schiff E.R., and Tong K.M.J. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus interferon study group. J. Gastroenterol. Hepatol. 15 (2000) 945-951
20. Montazeri G., Estakhri A., Mohamadnejad M., Nouri N., Montazeri F., Mohammadkani A., Derakhshan M.H., Zamani F., Samie S., and Malekzadeh R. Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B. BMC Gastroenterol. 5 (2005) 32-39
21. Muhlbauer M., Bosserhoff A.K., Hartmann A., Thasker W.E., Weiss T.S., Herfarth H., Lock G., Scholmerich J., and Hellebtand C. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 125 (2003) 1085-1093
22. Panasiuk A., Prokopowicz D., and Panasiuk B. Monocyte chemotactic protein-1 and soluble adhesion molecules as possible prognostic markers of the efficacy of antiviral treatment in chronic hepatitis C. World J. Gastroenterol. 10 (2004) 3639-3642
23. Panasiuk A., Wysocka J., Maciorkowska E., Panasiuk B., Prokopowicz D., Zak J., and Radomski K. Phagocytic and oxidative burst activity of neutrophils in the end stage of liver cirrhosis. World J. Gastroenterol. 11 (2005) 7661-7665
24. Park W.B., Lee K.D., Lee C.S., Jang H.C., Kim H.B., Lee H.S., Oh M.D., and Choe K.W. Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis. Diagn. Microbiol. Inf. Dis. 51 (2005) 227-230
25. Parola M., Leonarduzzi G., Robino G., Albano E., Ploi G., and Dianzani M.U. On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis. Free Radic. Biol. Med. 20 (1996) 251-359
26. Poynard T., Ratziu V., Benhamou Y., Di Martino V.D., Bedossa P., and Opolon P. Fibrosis in patients with chronic hepatitis C: detection and significance. Semina. Liver Dis. 20 (2000) 47-55
27. Rockey D.C., and Bissell D.M. Noninvasive measures of liver fibrosis. Hepatology 43 (2006) S113-S120
28. Rosenberg W.M.C., Voelker M., Thiel R., Becka M., Burt A., Schuppan D., Hubscher S., Roskams T., Pinzani M., and Arthur M.J.P. Serum markers detect the presence of liver fibrosis. Gastroenterology 127 (2004) 1704-1713
29. Ross A.D., Saldiva V., Oporto B., Carmichael F.J., Cameron R., and Israel Y. Circulating neutrophils and liver injury in rat models of experimental alcoholic liver disease. Alcohol Clin. Exp. Res. 22 (1998) 197-201
30. Saito J.M., and Maher J.J. Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. Gastroenterology 118 (2000) 1157-1168
31. Saitou Y., Shiraki K., Yamanaka Y., Yamaguchi Y., Kawakita T., Yamamoto N., Sugimoto K., Murata K., and Nakano T. Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease. World J. Gastroenterol. 11 (2005) 476-481
32. Simpson K.J., Henderson N.C., Bone-Larson C.L., Lukacs N.W., Hogaboam C.M., and Kunkel S.L. Chemokines in the pathogenesis of liver disease: so many players with poorly defined roles. Clin. Sci. 104 (2003) 47-63
33. Stickel F., Poeschl G., Schuppan D., Conradt C., Strenge-Hesse A., Fuchs F.S., Hofmann W.J., and Seitz H.K. Serum hyaluronate correlates with histological progression in alcoholic liver disease. Eur. J. Gastroenterol. Hepatol. 15 (2003) 945-950
34. Su L.J., Hsu S.L., Yang J.S., Tseng H.H., Huang S.F., and Huang C.Y.F. Global gene expression profiling of dimethylnitrosamine-induced liver fibrosis: From pathological and biochemical data to micro array analysis. Gene expression. 13 (2006) 107-132
35. Tao J., Peng H.Q., Cai W.M., Dong F.Q., Weng H.L., and Liu R.H. Influence factors of serum fibrosis markers in liver fibrosis. World J. Gastroenterol. 9 (2003) 2497-2500
36. Tsuneyama K., Harada K., Yasoshima M., Hiramatsu K., Mackay C.R., Mackay I.R., Gershwin M.E., and Nakanuma Y. Monocyte chemoattractant protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis. J. Pathol. 193 (2001) 102-109
37. Tsuruta S., Nakamuta M., Enjoji M., Kotoh K., Hiasa K., Egashira K., and Nawata H. Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats. Int. J. Mol. Med. 14 (2004) 837-842
38. Vigano S., Mannucci P.N., and D'Angelo A. The significance of protein C antigen in acute and chronic liver biliary diseases. Am. J. Clin. Path. 84 (1985) 454-458
39. Yoshikawa A., Kaido T., Seto S., Katsuura Y., and Imamura M. Activated protein C prevents multiple organ injury following extensive hepatectomy in cirrhotic rats. J. Hepatol. 33 (2000) 953-960
40. Zhang L.J., Yu J.P., Li D., Huang Y.H., Chen Z.X., and Wang X.Z. Effects of cytokines on carbon tetrachloride-induced hepatic fibrogenesis in rats. World J. Gastroenterol. 10 (2004) 77-81